Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections

doi:10.4254/wjh.v8.i31.1295

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11579)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-3) series.

Item

Count

PDF

498

WORD

322

HTML

5602

Tables (1-3)

303

Sum=6725

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

572

Download

1098

Sum=1670

Publishing Process of This Article

Item

Count

Browse

1178

Download

2006

Sum=3184

Nov 8, 2016 (publication date) through Jan 3, 2025

Times Cited of This Article

Times Cited (37)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Hepatol. Nov 8, 2016; 8(31): 1295-1308
Published online Nov 8, 2016. doi: 10.4254/wjh.v8.i31.1295

Table 2 Treatment interventions for unhealthy alcohol use and alcohol use disorder

Condition	Intervention
Unhealthy alcohol use	Brief intervention
	Motivational interviewing
AUD	Hospital detoxification
	Individual and group therapy
	Approved pharmacological treatments:
	Disulfiram
	Acamprosate
	Naltrexone
	Nalmefene
	Investigational treatments:
	Baclofene
	Topiramate
	Gabapentin

AUD: Alcohol use disorder.

Citation: Fuster D, Sanvisens A, Bolao F, Rivas I, Tor J, Muga R. Alcohol use disorder and its impact on chronic hepatitis C virus and human immunodeficiency virus infections. World J Hepatol 2016; 8(31): 1295-1308
URL: https://www.wjgnet.com/1948-5182/full/v8/i31/1295.htm
DOI: https://dx.doi.org/10.4254/wjh.v8.i31.1295